Post Market TRUST - U.S.A. Study
Public ClinicalTrials.gov record NCT02163525. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The TRUST (Treatment Results of Uterine Sparing Technologies) U.S.A. Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Post Market study is being conducted to compare the direct and indirect cost of three approaches (GFA, myomectomy, and uterine artery embolization) for the treatment of symptomatic uterine fibroids. In addition, data from this study is being used to satisfy the requirements of the United States Food and Drug Administration's 522 (post market surveillance) order.
Study identification
- NCT ID
- NCT02163525
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 114 participants
Conditions and interventions
Conditions
Interventions
- Global Fibroid Ablation (GFA) Procedure
- Abdominal or Laparoscopic Myomectomy Procedure
- Uterine Artery Embolization (UAE) Procedure
Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 12, 2014 (Type not available)
- Primary completion
- Jul 2019 (Actual)
- Completion
- Sep 12, 2025 (Actual)
- Last update posted
- Sep 30, 2025
2014 – 2025
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Los Angeles | Santa Monica | California | 90401 | — |
| Aspen Surgery Center/John Muir Hospital | Walnut Creek | California | 94598 | — |
| Augusta University | Augusta | Georgia | 30912-3360 | — |
| University of Chicago Medicine and Biological Sciences | Chicago | Illinois | 60637 | — |
| Brigham and Women's Hospital | Jamaica Plain | Massachusetts | 02130 | — |
| Henry Ford Hospital | West Bloomfield | Michigan | 48322 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Texas Fertility Center | Austin | Texas | 78731 | — |
| INOVA | Falls Church | Virginia | 60637 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02163525, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02163525 live on ClinicalTrials.gov.